162 related articles for article (PubMed ID: 34969235)
1. Challenges in
Kuligowska A; Baltaza W; Chomicz L; Machalińska A
Ann Agric Environ Med; 2021 Dec; 28(4):719-723. PubMed ID: 34969235
[No Abstract] [Full Text] [Related]
2. In vivo confocal microscopy and in vitro culture techniques as tools for evaluation of severe Acanthamoeba keratitis incidents.
Padzik M; Szaflik JP; Baltaza W; Perkowski K; Dybicz M; Chomicz L
Ann Parasitol; 2017; 63(4):341-346. PubMed ID: 29420872
[TBL] [Abstract][Full Text] [Related]
3. Comparison of chlorhexidine disinfectant in vitro effect on environmental and ocular Acanthamoeba strains, the amoebic agents of human keratitis − an emerging sight-threatening corneal disease in Poland.
Padzik M; Baltaza W; Szaflik JP; Hendiger E; Dybicz M; Chomicz L
Ann Parasitol; 2018; 64(3):229-233. PubMed ID: 30316219
[TBL] [Abstract][Full Text] [Related]
4. Effect of povidone iodine, chlorhexidine digluconate and toyocamycin on amphizoic amoebic strains, infectious agents of
Padzik M; Baltaza W; Conn DB; Szaflik JP; Chomicz L
Ann Agric Environ Med; 2018 Dec; 25(4):725-731. PubMed ID: 30586959
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Confocal Microscopy for the Diagnosis of Polymerase Chain Reaction-Positive Acanthamoeba Keratitis: A Case-Control Study.
De Craene S; Knoeri J; Georgeon C; Kestelyn P; Borderie VM
Ophthalmology; 2018 Feb; 125(2):161-168. PubMed ID: 28965660
[TBL] [Abstract][Full Text] [Related]
6. The rising tide of Acanthamoeba keratitis in Auckland, New Zealand: a 7-year review of presentation, diagnosis and outcomes (2009-2016).
McKelvie J; Alshiakhi M; Ziaei M; Patel DV; McGhee CN
Clin Exp Ophthalmol; 2018 Aug; 46(6):600-607. PubMed ID: 29412494
[TBL] [Abstract][Full Text] [Related]
7. Acanthamoeba keratitis in Mexico: Report of a clinical case and importance of sensitivity assays for a better outcome.
Omaña-Molina M; Vanzzini-Zago V; Hernández-Martínez D; Reyes-Batlle M; Castelan-Ramírez I; Hernández-Olmos P; Salazar-Villatoro L; González-Robles A; Ramírez-Flores E; Servín-Flores C; Flores-Alvarado V; Alcántara-Castro M; Lorenzo-Morales J
Exp Parasitol; 2019 Jan; 196():22-27. PubMed ID: 30472333
[TBL] [Abstract][Full Text] [Related]
8. Impact of implementation of polymerase chain reaction on diagnosis, treatment, and clinical course of Acanthamoeba keratitis.
Roth M; Balasiu A; Daas L; Holtmann C; Servera A; Walckling M; MacKenzie CR; Fuchsluger TA; Geerling G
Graefes Arch Clin Exp Ophthalmol; 2023 Jul; 261(7):1951-1959. PubMed ID: 36795161
[TBL] [Abstract][Full Text] [Related]
9. Acanthamoeba keratitis: 10-year study at a tertiary eye care center in Hong Kong.
Chin J; Young AL; Hui M; Jhanji V
Cont Lens Anterior Eye; 2015 Apr; 38(2):99-103. PubMed ID: 25496910
[TBL] [Abstract][Full Text] [Related]
10. Drug-resistant severe Acanthamoeba keratitis caused by rare T5 Acanthamoeba genotype.
Iovieno A; Oechsler RA; Ledee DR; Miller D; Alfonso EC
Eye Contact Lens; 2010 May; 36(3):183-4. PubMed ID: 20461886
[TBL] [Abstract][Full Text] [Related]
11. Emerging Threats for Human Health in Poland: Pathogenic Isolates from Drug Resistant Acanthamoeba Keratitis Monitored in terms of Their In Vitro Dynamics and Temperature Adaptability.
Chomicz L; Conn DB; Padzik M; Szaflik JP; Walochnik J; Zawadzki PJ; Pawłowski W; Dybicz M
Biomed Res Int; 2015; 2015():231285. PubMed ID: 26682216
[TBL] [Abstract][Full Text] [Related]
12. The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.
Robaei D; Carnt N; Minassian DC; Dart JK
Ophthalmology; 2014 Jul; 121(7):1383-8. PubMed ID: 24630688
[TBL] [Abstract][Full Text] [Related]
13. Specificity of in vivo confocal cornea microscopy in Acanthamoeba keratitis.
Füst Á; Tóth J; Simon G; Imre L; Nagy ZZ
Eur J Ophthalmol; 2017 Jan; 27(1):10-15. PubMed ID: 27312210
[TBL] [Abstract][Full Text] [Related]
14. Silver Nanoparticles as a Novel Potential Preventive Agent against Acanthamoeba Keratitis.
Hendiger EB; Padzik M; Sifaoui I; Reyes-Batlle M; López-Arencibia A; Rizo-Liendo A; Bethencourt-Estrella CJ; Nicolás-Hernández DS; Chiboub O; Rodríguez-Expósito RL; Grodzik M; Pietruczuk-Padzik A; Stępień K; Olędzka G; Chomicz L; Piñero JE; Lorenzo-Morales J
Pathogens; 2020 May; 9(5):. PubMed ID: 32380785
[TBL] [Abstract][Full Text] [Related]
15. Successive
Chomicz L; Szaflik JP; Szostakowska B; Izdebska J; Baltaza W; Łazicka-Gałecka M; Kuligowska A; Machalińska A; Zawadzki PJ; Szaflik J
Microorganisms; 2023 Apr; 11(5):. PubMed ID: 37317148
[TBL] [Abstract][Full Text] [Related]
16. Acanthamoeba genotypes T3 and T4 as causative agents of amoebic keratitis in Mexico.
Omaña-Molina M; Vanzzini-Zago V; Hernandez-Martinez D; Gonzalez-Robles A; Salazar-Villatoro L; Ramirez-Flores E; Oregon-Miranda E; Lorenzo-Morales J; Martinez-Palomo A
Parasitol Res; 2016 Feb; 115(2):873-8. PubMed ID: 26581373
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of in vitro dynamics of Acanthamoeba strains isolated from infected eyes as a useful tool in keratitis management.
Chomicz L; Padzik M; Szaflik JP; Nahorski WL; Kryczka T; Szaflik J
Exp Parasitol; 2014 Nov; 145 Suppl():S73-7. PubMed ID: 24999093
[TBL] [Abstract][Full Text] [Related]
18. Reduction of Acanthamoeba Cyst Density Associated With Treatment Detected by In Vivo Confocal Microscopy in Acanthamoeba Keratitis.
Wang YE; Tepelus TC; Gui W; Irvine JA; Lee OL; Hsu HY
Cornea; 2019 Apr; 38(4):463-468. PubMed ID: 30640249
[TBL] [Abstract][Full Text] [Related]
19. Resolution of
Avdagic E; Chew HF; Veldman P; Tu EY; Jafri M; Doshi R; Boggild AK; Reidy JJ; Farooq AV
Ocul Immunol Inflamm; 2021 Feb; 29(2):278-281. PubMed ID: 31829774
[No Abstract] [Full Text] [Related]
20. Acanthamoeba keratitis: an emerging disease gathering importance worldwide?
Lorenzo-Morales J; Martín-Navarro CM; López-Arencibia A; Arnalich-Montiel F; Piñero JE; Valladares B
Trends Parasitol; 2013 Apr; 29(4):181-7. PubMed ID: 23433689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
